QR Kodea

Cross-method comparison for BRAF p.V600 mutation cfDNA testing in Melanoma: BRAFI study

Background: BRAF p.V600 mutation is the most frequent molecular driver alteration in melanoma. Detection of BRAF mutations in circulating-free DNA (cfDNA) reflects the shedding of tumor DNA and offers a potential non-invasive biomarker for disease monitoring and prognosis. However, the lack of stand...

Deskribapen osoa

Gorde:
Egile Nagusiak: Clara Mayo de las Casas, Eloisa Jantus-Lewintre, Sebastian Ortiz Reina, Ana Drozdowskyj, Pablo Cerezuela-Fuentes, Jose Luis Manzano, Pablo Ayala de Miguel, Ana Arance Fernandez, Miguel Angel Berciano-Guerrero, Almudena Garcia-Castaño, Teresa Puertolas, Guillermo Crespo, Maria Quindos-Varela, Juan Francisco Rodriguez-Moreno, Alfonso Berrocal, Eva Muñoz-Couselo, Enrique Espinosa, Joselyn Valarezo, Susana Muñoz, Silvia Calabuig-Fariñas, Miguel Angel Molina, Rafael Rosell, Joan Anton Puig-Butille, Maria Gonzalez-Cao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2025-01-01
Saila:EJC Skin Cancer
Gaiak:
Melanoma
BRAF mutation
Liquid biopsy
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2772611825004598
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak